First Turn Management »

Adma Biologics shares owned by First Turn Management

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 665k 19.99

More positions owned by First Turn Management

Nuvalent Inc-a (NUVL)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Vaxcyte (PCVX)
Axsome Therapeutics (AXSM)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Natera (NTRA)
Intra Cellular Therapies (ITCI)
Crinetics Pharmaceuticals In (CRNX)
Transmedics Group (TMDX)
Arcellx Common Stock (ACLX)
Blueprint Medicines (BPMC)
Verona Pharma Sponsored Ads (VRNA)

View all positions for First Turn Management

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Nuveen Asset Management
Geode Capital Management
D. E. Shaw & Co
Two Sigma Advisers
AWM Investment Company
American Century Companies
Deutsche Bank Aktiengesellschaft
Dimensional Fund Advisors
Renaissance Technologies
Perpetual
Two Sigma Investments

View all funds holding Adma Biologics